Alterations of biochemical and two-dimensional biomechanical properties of human skin in diabetes mellitus as compared to effects of in vitro non-enzymatic glycation

Clinical Biomechanics

Volumn 15, Issue 5, 2000, Pages 379-386

  Reihsner, Roland ^a,b   Melling, Mahmoud ^a   Pfeiler, Wolfgang ^a   Menzel, Ernst Johannes ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

Aminoguanidine; Diabetes mellitus; Human skin; Multiaxial biomechanical analysis; Non enzymatic glycation

Indexed keywords

COLLAGEN;

ADULT; AGED; ARTICLE; AUTOPSY; BIOMECHANICS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLYCATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN STRUCTURE; RIGIDITY; SKIN;

AGED; AGED, 80 AND OVER; BIOMECHANICS; CADAVER; CASE-CONTROL STUDIES; DIABETES MELLITUS; ELASTICITY; ENZYME INHIBITORS; FEMALE; GLUCOSE-6-PHOSPHATE; GLYCOSYLATION; GUANIDINES; HUMANS; MIDDLE AGED; SKIN PHYSIOLOGY; STRESS, MECHANICAL; TENSILE STRENGTH;

EID: 0034029448     PISSN: 02680033     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-0033(99)00085-6     Document Type: Article

References (39)

1. Viidik A. Biomechanical behavior of soft connective tissues. In: Akkas N, editor. Progress in biomechanics. Alphen aan den Rijn, The Netherlands: Sijthoff & Noordhoff, 1979:75-113.
2. Lanir Y. The rheological behavior of skin: experimental results and a structural model. Biorheol. 16:1979;191-202.
3. Lanir Y., Fung Y.C. Two-dimensional mechanical properties of rabbit skin. I Experimental system. J Biomech. 7:1974;29-34.
4. Lanir Y., Fung Y.C. Two-dimensional mechanical properties of rabbit skin. II Experimental results. J Biomech. 7:1974;171-182.
5. Reihsner R., Menzel E.J. On the orthogonal anisotropy of human skin as a function of anatomical region. Connect Tissue Res. 34:1996;145-160.
6. Andreassen T.T., Seyer-Hansen K., Oxlund H. Biomechanical changes in connective tissues induced by experimental diabetes. Acta Endocrinol. 98:1981;432-436.
7. Hamlin C.R., Luschin J.H. Apparent accelerated aging of human collagen in diabetes mellitus. Diabetes. 24:1975;902-904.
8. Andreassen T.T., Seyer-Hansen K., Bailey A.J. Thermal stability, mechanical properties and reducible cross-links of rat tail tendon in experimental diabetes. Biochim Biophys Acta. 677:1981;313-317.
9. Schnider S., Kohn R.R. The effects of age and diabetes mellitus on the solubility and non-enzymatic glycosylation of human skin collagen. J Clin Invest. 67:1981;1630-1635.
10. Kohn R.R. Effects of age and diabetes mellitus on cyanogen bromide digestion of human dura mater collagen. Connect Tissue Res. 11:1983;169-173.
11. Buckingham B., Reiser K.M. Relationship between the content of lysyl oxidase-dependent crosslinks in skin collagen, nonenzymatic glycosylation and long-term complications in type I diabetes mellitus. J Clin Invest. 86:1990;1046-1054.
12. Bunn H.F. Non-enzymatic glycosylation of protein: relevance in diabetes. Am J Med. 70:1981;325-330.
13. Brownlee M., Vlassara H., Cerami A. Measurement of glycosylated amino acids and peptides from urine of diabetic patients using affinity chromatography. Diabetes. 29:1980;1044-1047.
14. Cohen M.P. Non-enzymatic glycosylation of proteins: clinical considerations. Special Topics in Endocrinology and Metabolism. 4:1982;69-92.
15. Kennedy L., Baynes J.W. Non-enzymatic glycosylation and the chronic complications of diabetes: an overview. Diabetologia. 26:1984;93-98.
16. Perejda A.J., Uitto J. Non-enzymatic glycosylation of collagen and other proteins: relationship to development of diabetic complications. Collagen Related Res. 2:1982;81-88.
17. Brownlee M., Vlassara H., Cerami A. Non-enzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med. 101:1984;527-537.
18. Monnier VM, Kohn RR, Cerami A. Accelerated age-related browning of collagen in diabetes mellitus. Proc Natl Acad Sci USA 1984;81:583-7.
19. Buckingham B.A., Uitto J., Sandborg C., Keens T., Roe T., Costin G., Kaufman F., Bernstein B., Landing B., Castellano A. Scleroderma-like changes in insulin-dependent diabetes mellitus: clinical and biochemical studies. Diabetes Care. 7:1984;163-169.
20. Vishwanath V., Frank K.E., Elmets C.A., Dauchot P.J., Monnier V.M. Glycation of skin collagen in type I diabetes mellitus. Correlation with long-term complications. Diabetes. 35:1986;916-921.
21. Monnier V.M., Vishwanath V., Frank K.E., Elmets C.A., Dauchot P., Kohn R.R. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N Engl J Med. 314:1986;403-408.
22. Monnier V.M., Elmets C.A., Frank K.E., Vishwanath V., Yamashita T. Age-related normalization of the browning rate of collagen in diabetic subjects without retinopathy. J Clin Invest. 78:1986;832-835.
23. Dominiczak M.H., Bell J., Cox N.H., McCruden D.C., Jones S.K., Finlay A.Y., Percy-Robb L.W., Frier B.M. Increased collagen-linked fluorescence in skin of young patients with type I diabetes mellitus. Diabetes Care. 13:1990;468-472.
24. Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes M. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. Proc Natl Acad Sci USA 1994;91:11704-8.
25. Soulis-Liparota T., Cooper M., Papazoglou D., Clarke B., Jerums G. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes. 40:1991;1328-1334.
26. Kihara M, Schmelzer JD, Poduslo JF, Curran GL, Nicklande KK, Low PA. Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc Natl Acad Sci USA 1991;88:6107-11.
27. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 1991;88:11555-8.
28. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care. 15:1992;1835-1843.
29. Stegemann H., Stalder K.H. Determination of hydroxyproline. Clin Chim Acta. 18:1967;267-273.
30. Lyons P.J., Bailey K.E., Dyer D.G., Dunn J.E., Baynes J.W. Decrease in skin collagen glycation with improved glycaemic control in patients with insulin dependent diabetes mellitus. J Clin Invest. 87:1991;1910-1915.
31. Oxlund H., Manschot J., Viidik A. The role of elastin in the mechanical properties of skin. J Biomech. 21:1988;213-218.
32. Reihsner R., Pfeiler W., Menzel E.J. Comparison of normal and in vitro aging by non-enzymatic glycation as verified by differential scanning calorimetry. Gerontol. 44:1998;85-90.
33. Bailey A.J., Sims T.J., Avery N.C., Mikes C.A. Chemistry of collagen cross-links: glucose mediated covalent cross-links of type IV collagen in lens capsules. Biochem J. 296:1993;489-496.
34. Bai P., Phua K., Hardt T., Cernadas M., Brodsky B. Glycation alters collagen fibril organization. Connect Tissue Res. 28:1992;1-12.
35. Hanna W., Friesen D., Bombardier C., Gladman D., Hanna A. Pathological features of thick skin. J Am Acad Dermatol. 16:1987;546-553.
36. Reihsner R., Balogh B., Menzel E.J. Two-dimensional elastic properties of human skin in terms of an incremental model at the in vivo configuration. Med Eng Phys. 17:1995;304-313.
37. Menzel E.J., Reihsner R. Comparison of the effects of different inhibitors on the non-enzymatic glycation of rat tail tendons and bovine serum albumin. Ann Clin Biochem. 33:1996;241-248.
38. Menzel E.J., Neumüller J., Sengoelge G., Reihsner R. Effects of aminoguanidine on adhesion molecule expression of human endothelial cells. Pharmacol. 55:1997;126-135.
39. Oxlund H., Andreassen T.T. Aminoguanidine treatment reduces the increase in collagen stability of rats with experimental diabetes mellitus. Diabetologia. 35:1992;19-25.